PDB Short entry for 1FJS HEADER BLOOD CLOTTING 08-AUG-00 1FJS TITLE CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH TITLE 2 FACTOR XA COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR XA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: HEAVY CHAIN, CATALYTIC DOMAIN; COMPND 5 EC: 3.4.21.6; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: COAGULATION FACTOR XA; COMPND 8 CHAIN: L; COMPND 9 FRAGMENT: LIGHT CHAIN, EPIDERMAL GROWTH FACTOR LIKE DOMAIN; COMPND 10 EC: 3.4.21.6 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 OTHER_DETAILS: EXTRACTED FROM BLOOD; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 OTHER_DETAILS: EXTRACTED FROM BLOOD KEYWDS PROTEIN INHIBITOR COMPLEX, COAGULATION COFACTOR, PROTEASE, BLOOD KEYWDS 2 CLOTTING EXPDTA X-RAY DIFFRACTION AUTHOR M.ADLER,M.WHITLOW REVDAT 8 13-MAR-24 1FJS 1 COMPND SOURCE REVDAT 7 09-AUG-23 1FJS 1 REMARK LINK REVDAT 6 04-OCT-17 1FJS 1 REMARK REVDAT 5 13-JUL-11 1FJS 1 VERSN REVDAT 4 24-FEB-09 1FJS 1 VERSN REVDAT 3 01-APR-03 1FJS 1 JRNL REVDAT 2 17-NOV-00 1FJS 1 JRNL REVDAT 1 04-OCT-00 1FJS 0 JRNL AUTH M.ADLER,D.D.DAVEY,G.B.PHILLIPS,S.H.KIM,J.JANCARIK, JRNL AUTH 2 G.RUMENNIK,D.R.LIGHT,M.WHITLOW JRNL TITL PREPARATION, CHARACTERIZATION, AND THE CRYSTAL STRUCTURE OF JRNL TITL 2 THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA. JRNL REF BIOCHEMISTRY V. 39 12534 2000 JRNL REFN ISSN 0006-2960 JRNL PMID 11027132 JRNL DOI 10.1021/BI001477Q REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.KAMATA,H.KAWAMOTO,T.HONMA,T.IWAMA,S.-H.KIM REMARK 1 TITL STRUCTURAL BASIS FOR CHEMICAL INHIBITION OF HUMAN BLOOD REMARK 1 TITL 2 COAGULATION FACTOR XA REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 95 6630 1998 REMARK 1 REFN ISSN 0027-8424 REMARK 1 DOI 10.1073/PNAS.95.12.6630 REMARK 1 REFERENCE 2 REMARK 1 AUTH H.BRANDSTETTER,A.KUHNE,W.BODE,R.HUBER,W.VON DER SAAL, REMARK 1 AUTH 2 K.WIRTHENSOHN,R.A.ENGH REMARK 1 TITL X-RAY STRUCTURE OF ACTIVE SITE-INHIBITED CLOTTING FACTOR XA. REMARK 1 TITL 2 IMPLICATIONS FOR DRUG DESIGN AND SUBSTRATE RECOGNITION REMARK 1 REF J.BIOL.CHEM. V. 271 29988 1996 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.271.47.29988 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.WHITLOW,D.O.ARNAIZ,B.O.BUCKMAN,ET AL. REMARK 1 TITL CRYSTALLOGRAPHIC ANALYSIS OF POTENT AND SELECTIVE FACTOR XA REMARK 1 TITL 2 INHIBITORS COMPLEXED TO BOVINE TRYPSIN REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 55 1395 1999 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444999007350 REMARK 1 REFERENCE 4 REMARK 1 AUTH G.B.PHILLIPS,B.O.BUCKMAN,D.D.DAVEY,ET AL. REMARK 1 TITL DISCOVERY OF REMARK 1 TITL 2 N-[2-[5-[AMINO(IMINO)METHYL]-2-HYDROXYPHENOXY]-3, REMARK 1 TITL 3 5-DIFLUORO-6-[3-(4, REMARK 1 TITL 4 5-DIHYDRO-1-METHYL-1H-IMIDAZOL-2-YL) REMARK 1 TITL 5 PHENOXY]PYRIDIN-4-YL]-N-METHYLGL Y CINE (ZK-807834): A REMARK 1 TITL 6 POTENT, SELECTIVE, AND ORALLY ACTIVE INHIBITOR OF THE BLOOD REMARK 1 TITL 7 COAGULATION ENZYME FACTOR XA REMARK 1 REF J.MED.CHEM. V. 41 3557 1998 REMARK 1 REFN ISSN 0022-2623 REMARK 1 DOI 10.1021/JM980280H REMARK 1 REFERENCE 5 REMARK 1 AUTH G.B.PHILLIPS,D.D.DAVEY,K.A.EAGEN,ET AL. REMARK 1 TITL DESIGN, SYNTHESIS, AND ACTIVITY OF REMARK 1 TITL 2 2,6-DIPHENOXYPYRIDINE-DERIVED FACTOR XA INHIBITORS REMARK 1 REF J.MED.CHEM. V. 42 1749 1999 REMARK 1 REFN ISSN 0022-2623 REMARK 1 DOI 10.1021/JM980667K REMARK 2 REMARK 2 RESOLUTION. 1.92 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.92 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.9 REMARK 3 NUMBER OF REFLECTIONS : 22885 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 891 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.92 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.01 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 79.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2323 REMARK 3 BIN R VALUE (WORKING SET) : 0.2570 REMARK 3 BIN FREE R VALUE : 0.2680 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 109 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2236 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 163 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 51.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.13600 REMARK 3 B22 (A**2) : 4.32000 REMARK 3 B33 (A**2) : -4.45700 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.976 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : 1.777 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO,PARAM11.WAT REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 FINAL REFINEMENT HAD A 400 TO 300 DEGREE SIMULATED REMARK 3 ANNEALING, FOLLOWED BY A POWELL MINIMIZATION, REMARK 3 B FACTOR OPTIMIZATION AND A FINAL POWELL MINIMIZATION. REMARK 4 REMARK 4 1FJS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-AUG-00. REMARK 100 THE DEPOSITION ID IS D_1000011649. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-NOV-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : X-GEN REMARK 200 DATA SCALING SOFTWARE : X-GEN REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29450 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.820 REMARK 200 RESOLUTION RANGE LOW (A) : 26.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05570 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.82 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.37900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.330 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIRECT REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: 1XKA REMARK 200 REMARK 200 REMARK: 1XKA STRUCTURE WAS SUPERIMPOSED ON 1FAX THEN USED FOR REMARK 200 DIRECT REPLACEMENT REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.03 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: DROP; 2 MICROLITER, 12 MG/ML FACTOR REMARK 280 XA, 50 MM TRIS PH 8.0, 75 MM NACL + 2 MICROLTER RESERVOIR: REMARK 280 RESERVOIR; 15-21% PEG-1500 AND 10MM CACL2, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.88500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.11500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.98000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.11500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.88500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.98000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 62 CG CD CE NZ REMARK 480 ARG A 150 CG CD NE CZ NH1 NH2 REMARK 480 LYS A 223 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 74 78.84 -115.68 REMARK 500 GLN A 75 146.56 157.11 REMARK 500 ARG A 115 -170.54 -171.45 REMARK 500 THR A 185B -84.88 -78.74 REMARK 500 LYS A 186 134.17 -33.49 REMARK 500 SER A 214 -62.27 -108.99 REMARK 500 LEU L 88 -113.10 55.02 REMARK 500 GLN L 98 -109.00 -129.13 REMARK 500 LYS L 122 -47.11 -131.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 507 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 70 OD2 REMARK 620 2 ASN A 72 O 88.4 REMARK 620 3 GLN A 75 O 176.3 88.1 REMARK 620 4 GLU A 77 OE2 77.4 82.8 103.3 REMARK 620 5 GLU A 80 OE2 91.7 160.2 92.0 77.9 REMARK 620 6 HOH A 612 O 83.5 91.3 95.4 160.1 108.4 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 507 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 508 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Z34 A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL L 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 506 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1FAX RELATED DB: PDB REMARK 900 FACTOR XA COMPLEXED TO DX-9065A REMARK 900 RELATED ID: 1XKA RELATED DB: PDB REMARK 900 FACTOR XA COMPLEXED TO FX-2212A REMARK 900 RELATED ID: 1QBN RELATED DB: PDB REMARK 900 TRYPSIN COMPLEXED TO ZK806688 REMARK 900 RELATED ID: 1QB1 RELATED DB: PDB REMARK 900 TRYPSIN COMPLEXED TO ZK806974 REMARK 900 RELATED ID: 1XKB RELATED DB: PDB REMARK 900 FACTOR XA COMPLEXED TO FX-2212A REMARK 900 RELATED ID: 1HCG RELATED DB: PDB REMARK 900 DES GLA FACTOR XA DBREF 1FJS A 16 244 UNP P00742 FA10_HUMAN 235 468 DBREF 1FJS L 87 138 UNP P00742 FA10_HUMAN 127 178 SEQRES 1 A 234 ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO SEQRES 2 A 234 TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE SEQRES 3 A 234 CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR SEQRES 4 A 234 ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL SEQRES 5 A 234 ARG VAL GLY ASP ARG ASN THR GLU GLN GLU GLU GLY GLY SEQRES 6 A 234 GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN SEQRES 7 A 234 ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL SEQRES 8 A 234 LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL SEQRES 9 A 234 ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER SEQRES 10 A 234 THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE SEQRES 11 A 234 GLY ARG THR HIS GLU LYS GLY ARG GLN SER THR ARG LEU SEQRES 12 A 234 LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS SEQRES 13 A 234 LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE SEQRES 14 A 234 CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN SEQRES 15 A 234 GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP SEQRES 16 A 234 THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY SEQRES 17 A 234 CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL SEQRES 18 A 234 THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR SEQRES 1 L 52 LYS LEU CYS SER LEU ASP ASN GLY ASP CYS ASP GLN PHE SEQRES 2 L 52 CYS HIS GLU GLU GLN ASN SER VAL VAL CYS SER CYS ALA SEQRES 3 L 52 ARG GLY TYR THR LEU ALA ASP ASN GLY LYS ALA CYS ILE SEQRES 4 L 52 PRO THR GLY PRO TYR PRO CYS GLY LYS GLN THR LEU GLU HET CA A 507 1 HET CL A 508 1 HET Z34 A 500 38 HET GOL A 502 6 HET GOL A 503 6 HET GOL A 504 6 HET GOL A 505 6 HET GOL A 506 6 HET GOL L 501 6 HETNAM CA CALCIUM ION HETNAM CL CHLORIDE ION HETNAM Z34 N-[2-[5-[AMINO(IMINO)METHYL]-2-HYDROXYPHENOXY]-3,5- HETNAM 2 Z34 DIFLUORO-6-[3-(4,5-DIHYDRO-1-METHYL-1H-IMIDAZOL-2-YL) HETNAM 3 Z34 PHENOXY]PYRIDIN-4-YL]-N-METHYLGLYCINE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 CA CA 2+ FORMUL 4 CL CL 1- FORMUL 5 Z34 C25 H24 F2 N6 O5 FORMUL 6 GOL 6(C3 H8 O3) FORMUL 12 HOH *163(H2 O) HELIX 1 3 ASP A 164 SER A 172 1 9 HELIX 2 4 PHE A 234 MET A 242 1 9 HELIX 3 5 LYS A 243 THR A 244 5 2 HELIX 4 6 LYS L 87 LEU L 91 5 5 HELIX 5 7 LEU L 91 CYS L 96 5 6 SHEET 1 A 7 GLN A 20 GLU A 21 0 SHEET 2 A 7 LYS A 156 PRO A 161 -1 N MET A 157 O GLN A 20 SHEET 3 A 7 THR A 135 GLY A 140 -1 O GLY A 136 N VAL A 160 SHEET 4 A 7 PRO A 198 PHE A 203 -1 O PRO A 198 N SER A 139 SHEET 5 A 7 THR A 206 TRP A 215 -1 O THR A 206 N PHE A 203 SHEET 6 A 7 GLY A 226 LYS A 230 -1 N ILE A 227 O TRP A 215 SHEET 7 A 7 MET A 180 ALA A 183 -1 O PHE A 181 N TYR A 228 SHEET 1 B 7 GLN A 30 ILE A 34 0 SHEET 2 B 7 GLY A 40 ILE A 46 -1 N PHE A 41 O LEU A 33 SHEET 3 B 7 TYR A 51 THR A 54 -1 N LEU A 53 O THR A 45 SHEET 4 B 7 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54 SHEET 5 B 7 ALA A 81 LYS A 90 -1 N GLU A 86 O ARG A 107 SHEET 6 B 7 LYS A 65 VAL A 68 -1 N VAL A 66 O HIS A 83 SHEET 7 B 7 GLN A 30 ILE A 34 -1 O LEU A 32 N ARG A 67 SHEET 1 C 2 PHE L 99 GLU L 103 0 SHEET 2 C 2 SER L 106 SER L 110 -1 O SER L 106 N GLU L 103 SHEET 1 D 2 TYR L 115 LEU L 117 0 SHEET 2 D 2 CYS L 124 PRO L 126 -1 N ILE L 125 O THR L 116 SSBOND 1 CYS A 22 CYS A 27 1555 1555 2.30 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.39 SSBOND 3 CYS A 122 CYS L 132 1555 1555 2.45 SSBOND 4 CYS A 168 CYS A 182 1555 1555 2.30 SSBOND 5 CYS A 191 CYS A 220 1555 1555 2.37 SSBOND 6 CYS L 89 CYS L 100 1555 1555 2.36 SSBOND 7 CYS L 96 CYS L 109 1555 1555 2.29 SSBOND 8 CYS L 111 CYS L 124 1555 1555 2.39 LINK OD2 ASP A 70 CA CA A 507 1555 1555 2.30 LINK O ASN A 72 CA CA A 507 1555 1555 2.16 LINK O GLN A 75 CA CA A 507 1555 1555 2.45 LINK OE2 GLU A 77 CA CA A 507 1555 1555 2.27 LINK OE2 GLU A 80 CA CA A 507 1555 1555 2.38 LINK CA CA A 507 O HOH A 612 1555 1555 1.83 SITE 1 AC1 6 ASP A 70 ASN A 72 GLN A 75 GLU A 77 SITE 2 AC1 6 GLU A 80 HOH A 612 SITE 1 AC2 5 ALA A 81 HIS A 83 THR A 113 ARG A 115 SITE 2 AC2 5 ARG A 125 SITE 1 AC3 17 LYS A 96 GLU A 97 THR A 98 PHE A 174 SITE 2 AC3 17 ASP A 189 ALA A 190 GLN A 192 SER A 195 SITE 3 AC3 17 VAL A 213 TRP A 215 GLY A 216 GLY A 218 SITE 4 AC3 17 GLY A 226 HOH A 605 HOH A 606 HOH A 608 SITE 5 AC3 17 HOH A 712 SITE 1 AC4 5 PRO L 126 GLY L 128 PRO L 129 PRO L 131 SITE 2 AC4 5 HOH L 617 SITE 1 AC5 3 GLU A 124A ARG A 125 GOL A 505 SITE 1 AC6 7 PRO A 111 MET A 131B ARG A 165 LYS A 230 SITE 2 AC6 7 HOH A 688 HOH A 700 HOH A 735 SITE 1 AC7 4 ILE A 89 LYS A 90 ASN A 92 TRP A 237 SITE 1 AC8 5 LEU A 123 PRO A 124 GOL A 502 HOH A 622 SITE 2 AC8 5 ARG L 113 SITE 1 AC9 7 LYS A 65 GLU A 84 ASP A 126 TRP A 127 SITE 2 AC9 7 SER A 130 HOH A 761 CYS L 100 CRYST1 55.770 71.960 80.230 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017931 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013897 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012464 0.00000